Your generosity helps us move forward
Every donation makes a difference by offering hope to patients and their families. Your support helps us discover new treatments and brings us closer to a world where kidney cancer can be better treated.
Bringing Hope to Cancer Patients
Kidney cancer is often diagnosed late, leaving limited treatment options and low survival rates. Thanks to your donations, which enabled the Cancer Research Society to grant us funding, my team has identified a molecule that targets kidney cancer cells and could improve treatments, especially in combination with existing therapies.
Dr. Sandra Turcotte
Associate Professor, Université de Moncton
Scientific Researcher, Atlantic Cancer Research Intitute
As a kidney cancer research specialist, my team and I are developing therapeutic strategies to improve treatment outcomes for this cancer, which is often diagnosed too late. In fact, 30% of kidney cancer patients are found to have metastases at diagnosis, resulting in an average survival of just 18 months. This prognosis highlights the need for improved and more effective treatment options.
As part of our research project, we discovered a promising molecule that specifically targets kidney cancer cells. We are currently exploring its potential as a treatment and developing tools to enhance its effectiveness, particularly when combined with existing therapies. This combined approach could give patients a better chance of survival.
These advancements are made possible, in part, thanks to the generosity of donors to the Cancer Research Society, which has provided grants over time.
We have also developed essential research models to evaluate the safety and effectiveness of new compounds and deepen our understanding of kidney cancer mechanisms. Your support is therefore essential to help us move forward in our work and to train the next generation of oncology researchers.
